1. Home
  2. SDHY vs TECX Comparison

SDHY vs TECX Comparison

Compare SDHY & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PGIM Short Duration High Yield Opportunities Fund

SDHY

PGIM Short Duration High Yield Opportunities Fund

HOLD

Current Price

$16.69

Market Cap

403.2M

Sector

Finance

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$23.18

Market Cap

393.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDHY
TECX
Founded
2020
2019
Country
United States
United States
Employees
N/A
51
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
403.2M
393.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SDHY
TECX
Price
$16.69
$23.18
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$80.40
AVG Volume (30 Days)
77.8K
543.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
8.46%
N/A
EPS Growth
N/A
N/A
EPS
1.07
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.01
$13.70
52 Week High
$17.18
$27.21

Technical Indicators

Market Signals
Indicator
SDHY
TECX
Relative Strength Index (RSI) 56.62 56.60
Support Level $16.46 $16.88
Resistance Level $16.83 $25.39
Average True Range (ATR) 0.13 2.10
MACD 0.00 0.10
Stochastic Oscillator 63.64 80.46

Price Performance

Historical Comparison
SDHY
TECX

About SDHY PGIM Short Duration High Yield Opportunities Fund

PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It mainly invests in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments (including derivatives) with similar economic characteristics.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: